HSP90AB1 and cancer: Among the reported chemical compounds targeting Hsp90, ATP competitive inhibitors form a dominant group, and quite a few compounds from this group are undergoing clinical trials for the treatment of cancer (Nabi et al., 2018, Sidera and Patsavoudi, 2014, Tatokoro et al., 2015).